How Increased Competition from Generic Drugs Has Affected Prices And Returns In The Pharmaceutical Industry

Abstract: This 14 page paper examines the way in which prices of branded drugs, and the related profit they create for the pharmaceutical companies, is impacted when patents expire and the branded drugs have to compete with generic products. The paper considers how the law of supply and demand manifests in this market where an increase in supply does result in a reduction of prices and to what extent this occurs. The paper also looks at the US Hatch-Waxman Act which was introduced to decrease the barriers of entry for the generic drugs whilst the patent periods were extended. The bibliography cites 5 sources.

Filename: TEdrugpr.rtf

Pages: 14

---

Catagory: Money & Banking / Corporate Finance

Subcatagory: Accounting & Personal Finance

---